Multiple uses of forest plots in presenting analysis results in health research.

[1]  Jonghanne Park,et al.  Addition of Hyperbaric Oxygen Therapy vs Medical Therapy Alone for Idiopathic Sudden Sensorineural Hearing Loss: A Systematic Review and Meta-analysis , 2018, JAMA otolaryngology-- head & neck surgery.

[2]  Liangjin Cheng,et al.  Association between p53 Arg72Pro polymorphism and colorectal cancer risk in Asian population: a meta-analysis. , 2018, Current problems in cancer.

[3]  Michael Kossmeier,et al.  Rainforest plots for the presentation of patient-subgroup analysis in clinical trials. , 2017, Annals of translational medicine.

[4]  N. Brunetti,et al.  Direct oral anti-coagulants compared with vitamin-K inhibitors and low-molecular-weight-heparin for the prevention of venous thromboembolism in patients with cancer: A meta-analysis study. , 2017, International journal of cardiology.

[5]  Ya-Hui Hsueh,et al.  Stroke, Bleeding, and Mortality Risks in Elderly Medicare Beneficiaries Treated With Dabigatran or Rivaroxaban for Nonvalvular Atrial Fibrillation. , 2016, JAMA internal medicine.

[6]  A. Sadlon,et al.  Direct oral anticoagulants in the elderly: systematic review and meta-analysis of evidence, current and future directions. , 2016, Swiss medical weekly.

[7]  S. Raina.  Interpreting forest plots and funnel plots in meta-analysis. , 2016, Neurology India.

[8]  P. Sedgwick.  How to read a forest plot in a meta-analysis , 2015, BMJ : British Medical Journal.

[9]  M. Voracek,et al.  Finding your way out of the forest without a trail of bread crumbs: development and evaluation of two novel displays of forest plots , 2015, Research synthesis methods.

[10]  Jeruza L Neyeloff,et al.  Meta-analyses and Forest plots using a microsoft excel spreadsheet: step-by-step guide focusing on descriptive data analysis , 2012, BMC Research Notes.

[11]  C. McCulloch,et al.  Accounting for the mortality benefit of drug-eluting stents in percutaneous coronary intervention: a comparison of methods in a retrospective cohort study , 2011, BMC medicine.

[12]  G. Lip,et al.  Apixaban in patients with atrial fibrillation. , 2011, The New England journal of medicine.

[13]  David Moher,et al.  Forest plots in reports of systematic reviews: a cross-sectional study reviewing current practice. , 2010, International journal of epidemiology.

[14]  E. Bass,et al.  Systematic Review: Comparative Effectiveness and Safety of Premixed Insulin Analogues in Type 2 Diabetes , 2008, Annals of Internal Medicine.

[15]  Denis Xavier,et al.  Effects of extended-release metoprolol succinate in patients undergoing non-cardiac surgery (POISE trial): a randomised controlled trial , 2008, The Lancet.

[16]  Stuart J Pocock,et al.  Figures in clinical trial reports: current practice & scope for improvement , 2007, Trials.

[17]  Steff Lewis,et al.  Forest plots: trying to see the wood and the trees , 2001, BMJ : British Medical Journal.

[18]  W. Hauser,et al.  The Protective Effect of Moderate Alcohol Consumption on Ischemic Stroke , 1999 .

[19]  T C Chalmers,et al.  Cumulative meta-analysis of therapeutic trials for myocardial infarction. , 1992, The New England journal of medicine.

[20]  K. McPherson,et al.  Secondary prevention of vascular disease by prolonged antiplatelet treatment , 1988, British medical journal.

[21]  T C Chalmers,et al.  The importance of beta, the type II error and sample size in the design and interpretation of the randomized control trial. Survey of 71 "negative" trials. , 1978, The New England journal of medicine.